Biological Information

Background Information:

Adenosine Na⁺-independent nucleoside transporters (Equilibrative nucleoside transporters, ENTs) are integral membrane proteins that mediate the bidirectional, passive transport of nucleosides and nucleobases across cellular membranes, driven by concentration gradients. ENTs play essential roles in nucleotide metabolism by enabling the recycling of purine and pyrimidine nucleosides for DNA synthesis, energy metabolism, and cellular signaling. In humans, four ENT isoforms (ENT1–ENT4) have been identified, each with distinct substrate specificities, tissue distribution patterns, and physiological functions. ENT1 and ENT2 are the most well-characterized, widely expressed, and primarily involved in transporting naturally occurring nucleosides and nucleobases. Beyond their physiological roles, ENTs are pharmacologically important for mediating the uptake of nucleoside-derived drugs, including anticancer and antiviral agents.

Family:

Transporter

Sub Family:

SLC29 / Nucleoside

Class:

SLC

Organism:

Human

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Detection Method:

Radiometry

Measured Response:

Scintillation

Testing Information

Procedure Summary:

This assay measures binding of [³H]Nitrobenzylthioinosine to sites associated with the transporter of adenosine. Human adenosine transporter membranes are prepared in Tris-HCl buffer pH 7.4. A 24 µg‡ aliquot of membrane is incubated with 0.5 nM [³H]Nitrobenzylthioinosine for 60 minutes at 25℃. Non-specific binding is estimated in the presence of 5 µM nitrobenzylthioinosine. Membranes are filtered and washed, the filters are then counted to determine [³H]Nitrobenzylthioinosine specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.

Ligand:

[³H] Nitrobenzylthioinosine

Ligand Kd (nM):

0.37

Ligand Concentration:

0.5 nM

Non Specific:

5 µM Nitrobenzylthioinosine

Incubation:

60 min at 25°C

Control Inhibitor:

NBTI

Criteria For Significance:

≥ 50% of max stimulation or inhibition

Test Concentration / Dose:

Suggested concentration for initial testing is 10 uM

Test Sample Requirements:

Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).

Minimum Order Quantity:

2

Turnaround Time

Standard:

15 Business Days

Reference Compound Data

PubChem ID

3108

Name

Dipyridamole

Measurement

0.0037μM - IC50

PubChem ID

65407

Name

NBTI

Measurement

0.00062μM - IC50

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei